Skip to content

Diarrhea syndrome diagnosis and treatment plan and clinical research of severe cases

Diarrhea syndrome diagnosis and treatment plan and clinical research of severe cases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-13004038
Enrollment
Unknown
Registered
2013-11-29
Start date
2013-11-14
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infectious diarrhea

Interventions

Treatment Group of Mild to moderate patients:Chinese medicine with western basis treatment
Control Group of Mild to moderate patients:Traditional Chinese medicine placebo with western
Treatment Group of severe patients:Chinese medicine with western medicine
Control Group of severe patients:Plecebo with western medicine

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medcine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 65 Years

Inclusion criteria

Inclusion criteria: Mild to moderate patients 1. Patients who meet the Western medicine diagnosis; 2. Patients who meet the Traditional Chinese medicine diagnosis; 3. Aged 6 to 65 years of age; 4. Voluntary participation in the Mild to moderate patients (1) Patients who meet the Western medicine diagnosis; (2) Patients who meet the Traditional Chinese medicine diagnosis; (3) Aged 6 to 65 years of age; (4) Voluntary participation in the trial, and signed informed consentunder the age of 18 patients need both guardian and himself signed the consent. Severe patients 1. Patients who meet the Western medicine diagnosis; 2. Patients who meet the Traditional Chinese medicine diagnosis; 3. Aged 6 to 65 years of age; 4. Voluntary participation in the trial, and signed informed consent, very severe and under the age of 18 patients need both guardian and himself signed the consent.

Exclusion criteria

Exclusion criteria: Mild to moderate patients 1. Age less than 6 or more than 65years old; 2. Severe patients; 3. Definite diagnosis of febrile diseases other than intestinal infectious diseases; 4. Intestinal infectious disease cholera, typhoid, dysentery; 5. With severe primary cardiac, liver,lung, kidney, Endocrine and metabolic systemnervous system and hemopoietic system diseases; 6. With ulcerative colitis, Crohn's disease, irritable bowel syndrome and the like in the history; 7. Pregnant or lactating women; 8. The patient cannot cooperate or psychiatric patients; 9. Antibiotics or other drugs used before. Severe patients 1. Age less than 6 or more than 65years old; 2. Definite diagnosis of febrile diseases other than intestinal infectious diseases; 3. Intestinal infectious disease cholera, typhoid, dysentery 4. With severe primary cardiac, liver, lung, kidney, Endocrine and metabolic system, nervous system and hemopoietic system diseases; 5. With ulcerative colitis, Crohn's disease, irritable bowel syndrome and the like in the history; 6. Pregnant or lactating women; 7. The patient cannot cooperate or psychiatric patients; 8. Antibiotics or other drugs used before.

Design outcomes

Primary

MeasureTime frame
Routine blood test;C reactive protein;Stool examination;Stool culture and drug sensitivity test;Serum electrolyte;excrement occult blood test;clinical symptom;routine urine test;

Countries

China

Contacts

Public ContactHua Zhou
zhouhuam@hotmail.com+86 13061717598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026